Synergistic co-operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II-induced angiotensinogen gene activation in vascular smooth muscle cells

FEBS Journal

Volumn 276, Issue 6, 2009, Pages 1720-1728

  Han, Mei ^b   Li, Ai Ying ^b   Meng, Fang ^b   Dong, Li Hua ^b   Zheng, Bin ^b   Hu, Hai Juan ^b   Nie, Lei ^b   Wen, Jin Kun ^a,b  

^a Department of Biochemistry and Molecular Biology ^*  (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Activator protein 1; Angiotensinogen; Gene regulation; Signal transducer and activator of transcription 5; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; MESSENGER RNA; PROTEIN C JUN; STAT5B PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; GENE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANGIOTENSINOGEN; BASE SEQUENCE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 61349178869     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06902.x     Document Type: Article

References (35)

1. Pfeffer JM, Fischer TA Pfeffer MA (1995) Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 57, 805 826.
2. Moreau P, d'Uscio LV, Shaw S, Takase H, Barton M Luscher TF (1997) Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. Circulation 96, 1593 1597.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169 180.
4. Corvol P Jeunemaitre X (1997) Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 18, 662 677.
5. Mascareno E, Dhar M Siddiqui MA (1998) Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA 95, 5590 5594.
6. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M, Hori S Ogawa S (1997) Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res 81, 611 617.
7. Schieffer B, Bernstein KE Marrero MB (1996) The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth. J Mol Med 74, 85 91.
8. McWhinney CD, Dostal D Baker K (1998) Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol 30, 751 761.
9. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P Bernstein KE (1995) Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247 250.
10. Guo Y, Mascareno E Siddiqui MA (2004) Distinct components of Janus kinase/signal transducer and activator of transcription signaling pathway mediate the regulation of systemic and tissue localized renin-angiotensin system. Mol Endocrinol 18, 1033 1041.
11. Xu W, Comhair SA, Zheng S, Chu SC, Marks-Konczalik J, Moss J, Haque SJ Erzurum SC (2003) STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. Am J Physiol 285, L137 L148.
12. Schuringa JJ, Timmer H, Luttickhuizen D, Vellenga E Kruijer W (2001) c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE). Cytokine 14, 78 87.
13. Zhang X, Wrzeszczynska MH, Horvath CM Darnell JE Jr. (1999) Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell Biol 19, 7138 7146.
14. Chinenov Y Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438 2452.
15. Shaulian E Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390 2400.
16. van Dam H Castellazzi M (2001) Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20, 2453 2464.
17. Ghislain JJ, Wong T, Nguyen M Fish EN (2001) The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J Interferon Cytokine Res 21, 379 388.
18. Haque SJ Williams BR (1998) Signal transduction in the interferon system. Semin Oncol 25, 14 22.
19. Ihle JN (1996) STATs: signal transducers and activators of transcription. Cell 84, 331 334.
20. Lee PJ, Camhi SL, Chin BY, Alam J Choi AM (2000) AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am J Physiol 279, L175 L182.
21. Look DC, Pelletier MR, Tidwell RM, Roswit WT Holtzman MJ (1995) Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270, 30264 30267.
22. Klett C, Nobiling R, Gierschik P Hackenthal E (1993) Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J Biol Chem 268, 25095 25107.
23. Sahar S, Dwarakanath RS, Reddy MA, Lanting L, Todorov I Natarajan R (2005) Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Circ Res 96, 1064 1071.
24. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A et al. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645 648.
25. Amiri F, Venema VJ, Wang X, Ju H, Venema RC Marrero MB (1999) Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 274, 32382 32386.
26. Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM Marrero MB (2003) S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 52, 2381 2388.
27. Kim S Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52, 11 34.
28. Cao H, Dronadula N, Rizvi F, Li Q, Srivastava K, Gerthoffer WT Rao GN (2006) Novel role for STAT-5B in the regulation of Hsp27-FGF-2 axis facilitating thrombin-induced vascular smooth muscle cell growth and motility. Circ Res 98, 913 922.
29. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson GW Hennighausen L (2004) Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24, 8037 8047.
30. Wang D, Stravopodis D, Teglund S, Kitazawa J Ihle JN (1996) Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 16, 6141 6148.
31. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG Kanakura Y (1999) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 18, 1367 1377.
32. Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ Peppelenbosch MP (2004) FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 94, 1032 1040.
33. Yang G Sigmund CD (1998) Regulatory elements required for human angiotensinogen expression in HepG2 cells are dispensable in transgenic mice. Hypertension 31, 734 740.
34. Dronadula N, Liu Z, Wang C, Cao H Rao GN (2005) STAT-3-dependent cytosolic phospholipase A2 expression is required for thrombin-induced vascular smooth muscle cell motility. J Biol Chem 280, 3112 3120.
35. Han M, Wen JK, Zheng B, Cheng Y Zhang C (2006) Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol 291, C50 C58.